Neurologic Disorders Therapeutics Market Size, Share, and Growth 2025-2031
Neurologic Disorders Therapeutics Market Report Analysis
Neurologic Disorders Therapeutics Market
-
CAGR (2025 - 2031)XX% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Biogen Inc
- F Hoffmann La Roche Ltd
- Johnson Johnson Services Inc
- Novartis AG
- Pfizer Inc
- Sage Therapeutics Inc
- Boehringer Ingelheim International GmbH
- Bayer AG
- GlaxoSmithKline plc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Indication
- Parkinson Diseases
- Alzheimer Diseases
- Psychotic Disorders
- Epileptic Disorders
- Autism Disorders
- Brain Tumor Diseases
By Drug Class
- ACE Inhibitors
- NMDA Antagonist
- D2 Antagonists
By Application
- Central Nervous System
- Peripheral Nervous System
Get Free Sample For